Rapid and simultaneous multiple detection of a tripledemic using a dual-gate oxide semiconductor thin-film transistor-based immunosensor
- Authors
- Jeong, Sehun; Son, Seong Uk; Kim, Jingyu; Cho, Seong-In; Kang, Taejoon; Kim, Sunjoo; Lim, Eun-Kyung; Ko Park, Sang-Hee
- Issue Date
- Dec-2023
- Publisher
- Pergamon Press Ltd.
- Keywords
- Dual-gate thin-film transistor; Multiple detection; Point-of-care test; Tripledemic
- Citation
- Biosensors and Bioelectronics, v.241
- Indexed
- SCIE
SCOPUS
- Journal Title
- Biosensors and Bioelectronics
- Volume
- 241
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/68018
- DOI
- 10.1016/j.bios.2023.115700
- ISSN
- 0956-5663
1873-4235
- Abstract
- The simultaneous infection with a tripledemic—simultaneous infection with influenza A pH1N1 virus (Flu), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and respiratory syncytial virus (RSV)—necessitates the development of accurate and fast multiplex diagnostic tests. The coronavirus disease 2019 (COVID-19) pandemic has emphasized the importance of virus detection. Field-effect transistor (FET)-based immuno-biosensors have a short detection time and do not require labeling or polymerase chain reaction. This study demonstrates the rapid, sensitive detection of influenza A pH1N1, SARS-CoV-2, and RSV using a multiplex immunosensor based on a dual-gate oxide semiconductor thin-film transistor (TFT), a type of FET. The dual-gate oxide TFT was modified by adjusting both top and bottom gate insulators to improve capacitive coupling to approximately 120-fold amplification, exhibiting a high pH sensitivity of about 10 V/pH. The dual-gate oxide TFT-based immunosensor detected the target proteins (hemagglutinin (HA) protein of Flu, spike 1 (S1) protein of SARS-CoV-2, and fusion protein of RSV) of each virus, with a limit of detection of approximately 1 fg/mL. Cultured viruses in phosphate-buffered saline or artificial saliva and clinical nasopharynx samples were detected in 1-μL sample volumes within 60 s. This promising diagnosis could be potentially as point-of-care tests to facilitate a prompt response to future pandemics with high sensitivity and multiplexed detection without pretreatment. © 2023 Elsevier B.V.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.